Onconetix, Inc. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate
Onconetix, Inc. (ONCO) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate of 96.36% for the 1-month period ending 2022-10-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate · last filed 2023-03-09
- 2022-10-31: Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 1 month 96.36%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate 1 month |
|---|---|
| 2022-10-31 | 96.36% 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |